Related Experiment Video
Updated: Dec 20, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Infection with SARS-CoV-2 causes abnormal laboratory results of multiple organs in patients
Ai-Ping Yang1, Hui-Ming Li2, Wen-Qiang Tao3
1Department of Clinical Laboratory, Zhejiang Xiaoshan Hospital, Hangzhou, Zhejiang Province, China.
Insights
Key laboratory markers like neutrophil-to-lymphocyte ratio (NLR) and D-dimer (D-D) can help identify severe COVID-19 cases early. Lymphopenia and cytokine storm severity correlate with disease progression.
Area of Science:
- Immunology
- Clinical Medicine
- Virology
Background:
- Coronavirus disease 2019 (COVID-19) presents with diverse clinical manifestations.
- Understanding laboratory markers is crucial for assessing disease severity and prognosis.
Purpose of the Study:
- To evaluate the clinical significance of abnormal laboratory results in COVID-19 patients.
- To aid clinicians in accurate diagnosis and treatment strategies for COVID-19.
Main Methods:
- Analysis of peripheral blood samples from 93 COVID-19 patients.
- Flow cytometry for lymphocyte subsets and immunoassays for cytokine profiles.
- Statistical analysis including ROC curves and COX regression models for prognostic value.
Main Results:
- Elevated neutrophil-to-lymphocyte ratio (NLR), D-dimer (D-D), and specific cytokines (IL-6, IL-10, IL-2, IFN-γ) correlated with COVID-19 severity.
- Lymphopenia and a proinflammatory cytokine storm were more pronounced in severe cases.
- D-dimer levels significantly increased with disease severity, posing a risk for disseminated intravascular coagulation.
- Renal function damage often preceded cardiac and liver dysfunction in severe COVID-19.
Conclusions:
- Lymphopenia and cytokine storm severity are associated with COVID-19 disease severity.
- Advanced age, NLR, D-D, and cytokine levels are potential prognostic factors for early identification of severe COVID-19.
- Laboratory markers provide valuable insights into COVID-19 progression and patient outcomes.
Aim:
To evaluate the clinical value of abnormal laboratory results of multiple organs in patients with coronavirus disease 2019 (COVID-2019) and to help clinicians perform correct treatment.
Results:
Elevated neutrophil-to-LYM ratio (NLR), D-dimer(D-D), interleukin (IL)-6, IL-10, IL-2, interferon-Y, and age were significantly associated with the severity of illness. However, significant and sustained decreases were observed in the LYM subset (p<0.05). D-D, T cell counts, and cytokine levels in severe COVID-19 patients who survived the disease gradually recovered at later time points to levels that were comparable to those of mild cases. Second, D-D increased from 0.5 to 8, and the risk ratio increased from 2.75 to 55, eventually leading to disseminated intravascular coagulation. Moreover, the acute renal function damage occurred earlier than abnormal heart and liver functions (p<0.05).
Conclusions:
The degrees of lymphopenia and proinflammatory cytokine storm were higher in severe COVID-19 patients than in mild cases. The degree was associated with the disease severity. Advanced age, NLR, D-D, and cytokine levels may serve as useful prognostic factors for the early identification of severe COVID-19 cases.
Methods:
Peripheral blood samples were collected from 93 confirmed COVID-19 patients. The samples were examined for lymphocyte (LYM) subsets by flow cytometry and cytokine profiles by specific immunoassays. The receiver operating characteristic curve was applied to determine the best diagnostic thresholds for laboratory results, and principal component analysis was used to screen the major risk factors. The prognostic values were assessed using the Kaplan-Meier curve and univariate and multivariate COX regression models.
More Related Videos
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
Pneumonia III: Complications and Assessment
Myocarditis II: Clinical Features and Diagnostic Tests
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

